-1||-1|-1||-1||hepatotoxicity||10019851
-1||-1|-1||-1||hemorrhage||10055798
-1||-1|-1||-1||dermatological toxicity||10059516
-1||-1|-1||-1||hypertension||10020772
-1||-1|-1||-1||cardiac ischemia||10028600
-1||-1|-1||-1||cardiac infarction||10028596
-1||-1|-1||-1||reversible posterior leukoencephalopathy syndrome||10071066
-1||-1|-1||-1||rpls||10071066
-1||-1|-1||-1||gastrointestinal perforation||10018001
-1||-1|-1||-1||gastrointestinal fistula||10017877
-1||-1|-1||-1||asthenia||10003549
-1||-1|-1||-1||fatigue||10016256
-1||-1|-1||-1||hfsr||10033553
-1||-1|-1||-1||diarrhea||10012735
-1||-1|-1||-1||decreased appetite||10061428
-1||-1|-1||-1||decreased food intake||10063743
-1||-1|-1||-1||mucositis||10028116
-1||-1|-1||-1||dysphonia||10013952
-1||-1|-1||-1||infection||10021789
-1||-1|-1||-1||pain||10033371
-1||-1|-1||-1||decreased weight||10047895
-1||-1|-1||-1||gastrointestinal pain||10017999
-1||-1|-1||-1||abdominal pain||10000081
-1||-1|-1||-1||rash||10037844
-1||-1|-1||-1||fever||10037660
-1||-1|-1||-1||nausea||10028813
-1||-1|-1||-1||hand-foot skin reaction||10033553
-1||-1|-1||-1||ppe||10033553
-1||-1|-1||-1||drug eruption||10013687
-1||-1|-1||-1||erythematous rash||10037855
-1||-1|-1||-1||generalized rash||10037858
-1||-1|-1||-1||macular rash||10037867
-1||-1|-1||-1||maculo-papular rash||10037868
-1||-1|-1||-1||papular rash||10037876
-1||-1|-1||-1||pruritic rash||10037884
-1||-1|-1||-1||weight loss||10047895
-1||-1|-1||-1||fatal outcomes||10011906
-1||-1|-1||-1||headache||10019211
-1||-1|-1||-1||anemia||10002034
-1||-1|-1||-1||thrombocytopenia||10043554
-1||-1|-1||-1||neutropenia||10029354
-1||-1|-1||-1||lymphopenia||10025327
-1||-1|-1||-1||hypocalcemia||10020947
-1||-1|-1||-1||hypokalemia||10021015
-1||-1|-1||-1||hyponatremia||10021036
-1||-1|-1||-1||hypophosphatemia||10021058
-1||-1|-1||-1||hyperbilirubinemia||10020578
-1||-1|-1||-1||increased ast||10003481
-1||-1|-1||-1||increased alt||10001551
-1||-1|-1||-1||proteinuria||10037032
-1||-1|-1||-1||increased inr||10022595
-1||-1|-1||-1||increased international normalized ratio||10022595
-1||-1|-1||-1||increased lipase||10024574
-1||-1|-1||-1||increased amylase||10002016
-1||-1|-1||-1||alopecia||10001760
-1||-1|-1||-1||vomiting||10047700
-1||-1|-1||-1||hypothyroidism||10021114
-1||-1|-1||-1||musculoskeletal stiffness||10052904
-1||-1|-1||-1||hypersensitivity reaction||10020751
-1||-1|-1||-1||fatal||10011906
-1||-1|-1||-1||gastrointestinal fistulae||10017877
-1||-1|-1||-1||wound healing complications||10021519|10053692
-1||-1|-1||-1||fetal harm||10016852
-1||-1|-1||-1||drug induced liver injury||10072268
-1||-1|-1||-1||fatal outcome||10011906
-1||-1|-1||-1||liver lymphocyte infiltration||10062049
-1||-1|-1||-1||hepatocyte necrosis||10019692
-1||-1|-1||-1||hepatic failure||10019663
-1||-1|-1||-1||adverse reactions involving the skin||10040831
-1||-1|-1||-1||adverse reactions involving subcutaneous tissues||10040831
-1||-1|-1||-1||palmar-plantar erythrodysesthesia||10033553
-1||-1|-1||-1||erythema multiforme||10015218
-1||-1|-1||-1||stevens johnson syndrome||10042033
-1||-1|-1||-1||toxic epidermal necrolysis||10044223
-1||-1|-1||-1||hypertensive crisis||10020802
-1||-1|-1||-1||myocardial ischemia||10028600
-1||-1|-1||-1||myocardial infarction||10028596
-1||-1|-1||-1||subcortical vasogenic edema||10067275
-1||-1|-1||-1||fatal events||10011906
